SAO PAULO (Reuters) – Brazilian health regulator Anvisa has granted full approval to a COVID-19 vaccine developed by Pfizer Inc and Germany’s BioNTech SE, the agency said in a Tuesday statement.
That makes it the first vaccine against the novel coronavirus to receive full approval in Brazil, Anvisa said. Other vaccines developed by AstraZeneca and China’s Sinovac Biotech Ltd, have only been approved for emergency use so far.
(Reporting by Eduardo Simoes; Writing by Gabriel Stargardter; Editing by Brad Haynes)
